United States · FDA National Drug Code directory
Naproxen
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68462-190_16372549-a419-4920-a200-5128017570ed
- Product NDC
- 68462-190
- Form
- TABLET
- Composition / generic term
- Naproxen
- Labeler
- Glenmark Pharmaceuticals Inc., USA
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20070701
- Source listing expiry
- 20261231
Source-listed ingredients
- NAPROXEN — 500 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (68462-190-01) · 68462-190-01
- 500 TABLET in 1 BOTTLE (68462-190-05) · 68462-190-05
- 30 TABLET in 1 BOTTLE (68462-190-30) · 68462-190-30
- 50 TABLET in 1 BOTTLE (68462-190-50) · 68462-190-50
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →